Global Surgical Heart Valves Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Surgical Heart Valves market size will reach US$ 21140 million by 2031.
Surgical Heart Valves are prosthetic devices implanted in the heart through open-heart surgery to replace or repair damaged or diseased natural heart valves, such as the aortic, mitral, tricuspid, or pulmonary valves. These valves are essential in restoring normal blood flow direction and preventing backflow, thereby improving cardiac function and patient quality of life. Surgical heart valves are typically classified into two main types: mechanical valves, made from durable materials like titanium and pyrolytic carbon, which require lifelong anticoagulation therapy; and bioprosthetic (tissue) valves, made from animal or human tissue, which have lower thrombogenicity and generally do not require long-term anticoagulation. The choice of valve depends on patient age, lifestyle, health condition, and clinical considerations. Surgical heart valve replacement remains a standard treatment for severe valve stenosis or regurgitation, especially when transcatheter approaches are not suitable. Advances in valve design and surgical techniques have significantly increased the safety, durability, and hemodynamic performance of these life-saving devices.
The classification of Transcatheter Heart Valve Replacement and Repair includes TAVR, TPVR and TMVR. The proportion of TAVR in 2019 is about 80%.
North America and Europe are the largest consumption place, with a revenue market share nearly 95% in 2019. APAC has the highest growth in the market. The market is expected to grow at a faster pace due to significant developments and sales in countries such as India, Malaysia, South Korea and China.
Market competition is not intense. Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
LPI (LP Information)' newest research report, the “Surgical Heart Valves Industry Forecast” looks at past sales and reviews total world Surgical Heart Valves sales in 2024, providing a comprehensive analysis by region and market sector of projected Surgical Heart Valves sales for 2025 through 2031. With Surgical Heart Valves sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Surgical Heart Valves industry.
This Insight Report provides a comprehensive analysis of the global Surgical Heart Valves landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Surgical Heart Valves portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Surgical Heart Valves market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Surgical Heart Valves and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Surgical Heart Valves.
This report presents a comprehensive overview, market shares, and growth opportunities of Surgical Heart Valves market by product type, application, key players and key regions and countries.
Segmentation by Type:
TAVR
TPVR
TMVR
Segmentation by Application:
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratory
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Venus Medtech
Meril Life Sciences
Braile Biomedica
Please note: The report will take approximately 2 business days to prepare and deliver.
Surgical Heart Valves are prosthetic devices implanted in the heart through open-heart surgery to replace or repair damaged or diseased natural heart valves, such as the aortic, mitral, tricuspid, or pulmonary valves. These valves are essential in restoring normal blood flow direction and preventing backflow, thereby improving cardiac function and patient quality of life. Surgical heart valves are typically classified into two main types: mechanical valves, made from durable materials like titanium and pyrolytic carbon, which require lifelong anticoagulation therapy; and bioprosthetic (tissue) valves, made from animal or human tissue, which have lower thrombogenicity and generally do not require long-term anticoagulation. The choice of valve depends on patient age, lifestyle, health condition, and clinical considerations. Surgical heart valve replacement remains a standard treatment for severe valve stenosis or regurgitation, especially when transcatheter approaches are not suitable. Advances in valve design and surgical techniques have significantly increased the safety, durability, and hemodynamic performance of these life-saving devices.
The classification of Transcatheter Heart Valve Replacement and Repair includes TAVR, TPVR and TMVR. The proportion of TAVR in 2019 is about 80%.
North America and Europe are the largest consumption place, with a revenue market share nearly 95% in 2019. APAC has the highest growth in the market. The market is expected to grow at a faster pace due to significant developments and sales in countries such as India, Malaysia, South Korea and China.
Market competition is not intense. Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
LPI (LP Information)' newest research report, the “Surgical Heart Valves Industry Forecast” looks at past sales and reviews total world Surgical Heart Valves sales in 2024, providing a comprehensive analysis by region and market sector of projected Surgical Heart Valves sales for 2025 through 2031. With Surgical Heart Valves sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Surgical Heart Valves industry.
This Insight Report provides a comprehensive analysis of the global Surgical Heart Valves landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Surgical Heart Valves portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Surgical Heart Valves market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Surgical Heart Valves and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Surgical Heart Valves.
This report presents a comprehensive overview, market shares, and growth opportunities of Surgical Heart Valves market by product type, application, key players and key regions and countries.
Segmentation by Type:
TAVR
TPVR
TMVR
Segmentation by Application:
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratory
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Venus Medtech
Meril Life Sciences
Braile Biomedica
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
94 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Surgical Heart Valves Market Size by Player
- 4 Surgical Heart Valves by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Surgical Heart Valves Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
